Impact of Smokeless Tobacco Products on Cardiovascular Disease: Implications for Policy, Prevention, and Treatment
Authors:
- Mariann R. PianoMPMariann R. Piano
- Neal L. BenowitzNBNeal L. Benowitz
- Garret A. FitzGeraldGFGarret A. FitzGerald
- Susan CorbridgeSCSusan Corbridge
- Janie HeathJHJanie Heath
- Ellen HahnEHEllen Hahn
- Terry F. PechacekTPTerry F. Pechacek
- George HowardGHGeorge Howard
- on behalf of the American Heart Association Council on Cardiovascular NursingONon behalf of the American Heart Association Council on Cardiovascular Nursing
- 12 October 2010
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 122 (15) , 1520-1544
Abstract
No abstract availableKeywords
This publication has 122 references indexed in Scilit:
- Patterns of dual use of cigarettes and smokeless tobacco among US males: findings from national surveysTobacco Control, 2009
- Heart Disease and Stroke Statistics—2009 UpdateCirculation, 2009
- Quitting cigarettes completely or switching to smokeless tobacco: do US data replicate the Swedish results?Tobacco Control, 2009
- New and traditional smokeless tobacco: Comparison of toxicant and carcinogen levelsNicotine & Tobacco Research, 2008
- Smokeless Tobacco and the Risk of StrokeEpidemiology, 2008
- Is low-nicotine Marlboro snus really snus?Harm Reduction Journal, 2008
- Tobacco-related disease mortality among men who switched from cigarettes to spit tobaccoTobacco Control, 2007
- Role of snus in initiation and cessation of tobacco smoking in SwedenTobacco Control, 2006
- Sodium Intake from Smokeless TobaccoNew England Journal of Medicine, 1988
- Blood pressure in smokers and nonsmokers: Epidemiologic findingsAmerican Heart Journal, 1986